ID24439A - USE OF TIAZOLIDINDION FOR HYPERGLICEMIA TREATMENT - Google Patents

USE OF TIAZOLIDINDION FOR HYPERGLICEMIA TREATMENT

Info

Publication number
ID24439A
ID24439A IDW20000670A ID20000670A ID24439A ID 24439 A ID24439 A ID 24439A ID W20000670 A IDW20000670 A ID W20000670A ID 20000670 A ID20000670 A ID 20000670A ID 24439 A ID24439 A ID 24439A
Authority
ID
Indonesia
Prior art keywords
tiazolidindion
hyperglicemia
treatment
hyperglicemia treatment
Prior art date
Application number
IDW20000670A
Other languages
Indonesian (id)
Inventor
Robin E Buckingham
Stephen A Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ID24439A publication Critical patent/ID24439A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/4261,3-Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/427Thiazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDW20000670A 1997-10-13 1998-10-12 USE OF TIAZOLIDINDION FOR HYPERGLICEMIA TREATMENT ID24439A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9721692.3A GB9721692D0 (en) 1997-10-13 1997-10-13 Novel treatment

Publications (1)

Publication Number Publication Date
ID24439A true ID24439A (en) 2000-07-20

Family

ID=10820481

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000670A ID24439A (en) 1997-10-13 1998-10-12 USE OF TIAZOLIDINDION FOR HYPERGLICEMIA TREATMENT

Country Status (24)

Country Link
EP (1) EP1023057A1 (en)
JP (1) JP2001519383A (en)
KR (1) KR20010024482A (en)
CN (1) CN1281358A (en)
AP (1) AP1223A (en)
AU (1) AU9547198A (en)
BG (1) BG104405A (en)
BR (1) BR9815220A (en)
CA (1) CA2305289A1 (en)
CZ (1) CZ20001298A3 (en)
EA (1) EA200000418A1 (en)
GB (1) GB9721692D0 (en)
HR (1) HRP20000256A2 (en)
HU (1) HUP0003673A3 (en)
ID (1) ID24439A (en)
IL (1) IL135515A0 (en)
NO (1) NO20001897L (en)
OA (1) OA11519A (en)
PL (1) PL339804A1 (en)
SK (1) SK5322000A3 (en)
TR (1) TR200000957T2 (en)
UA (1) UA66809C2 (en)
WO (1) WO1999018944A1 (en)
YU (1) YU28700A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002521326A (en) * 1998-07-21 2002-07-16 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー Use of a glucose uptake enhancer to reduce apoptosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3856378T2 (en) * 1987-09-04 2000-05-11 Beecham Group P.L.C., Brentford Substituted thiazolidinedione derivatives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5478852C1 (en) * 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus

Also Published As

Publication number Publication date
IL135515A0 (en) 2001-05-20
HUP0003673A3 (en) 2001-12-28
SK5322000A3 (en) 2000-09-12
BR9815220A (en) 2000-11-14
YU28700A (en) 2003-10-31
NO20001897D0 (en) 2000-04-12
UA66809C2 (en) 2004-06-15
BG104405A (en) 2000-12-29
PL339804A1 (en) 2001-01-02
CZ20001298A3 (en) 2001-08-15
HRP20000256A2 (en) 2000-12-31
TR200000957T2 (en) 2000-08-21
EA200000418A1 (en) 2000-10-30
NO20001897L (en) 2000-06-09
AU9547198A (en) 1999-05-03
CN1281358A (en) 2001-01-24
HUP0003673A2 (en) 2001-10-28
CA2305289A1 (en) 1999-04-22
EP1023057A1 (en) 2000-08-02
KR20010024482A (en) 2001-03-26
JP2001519383A (en) 2001-10-23
OA11519A (en) 2004-02-09
AP2000001788A0 (en) 2000-06-30
GB9721692D0 (en) 1997-12-10
AP1223A (en) 2003-11-13
WO1999018944A1 (en) 1999-04-22

Similar Documents

Publication Publication Date Title
PT1032396E (en) STERILIZATION OF GLUCOCORTICOESTEROIDS
NO983266D0 (en) Distributed Treatment
DK0951447T3 (en) water Treatment
NO992806D0 (en) Therapeutic agents
DE69524138D1 (en) Skin treatment agents
ID18679A (en) USE OF FURTHER THERAPY
NO20003065L (en) Combination for effective treatment of impotence
DE69807225D1 (en) Nonwoven TREATMENT
DE69833493D1 (en) TISSUE
ID21948A (en) USE OF 1-HYDROXY-2-PYRIDON FOR TREATMENT OF SKIN INFECTIONS
NO983263L (en) Distributed treatment
ID27214A (en) TRIAZOLOPIRIDINA FOR TREATMENT OF TROMBOSIS DISORDERS
IS4789A (en) treatment Compounds
ID24270A (en) REMOVAL OF KERATOTIC CONSTITIONS
ID23437A (en) REMOVAL OF KERATOTIC CONSTITIONS
ID24922A (en) COMBINATION THERAPY FOR TREATMENT OF AIDS
ATE235494T1 (en) IMINO-AZA ANTHRACYCLONE DERIVATIVES FOR THE TREATMENT OF AMYLOIDOSIS
DE69812879D1 (en) PATIENTS LIEGE
ID24439A (en) USE OF TIAZOLIDINDION FOR HYPERGLICEMIA TREATMENT
ID17383A (en) LATEST USE OF SISTINA DOWN
FI974508A (en) Type of device
ID24521A (en) USE OF TIAZOLIDINDION FOR HYPERGLICEMIA TREATMENT
NO20000274D0 (en) Treatment of fluids
ID29414A (en) TREATMENT OF DEPRESSION
ID17459A (en) ELEMENTS OF TREATMENT